Literature DB >> 29105060

Cannabinoid receptor 1/2 double-knockout mice develop epilepsy.

Shane Rowley1, Xiaofei Sun2, Isabel V Lima1,3, Alexandra Tavenier2, Antonio Carlos Pinheiro de Oliveira3, Sudhansu K Dey2, Steve C Danzer1,4.   

Abstract

The endocannabinoid system has gained attention as an important modulator of activity in the central nervous system. Initial studies focused on cannabinoid receptor 1 (CB1), which is widely expressed in the brain, but recent work also implicates cannabinoid receptor 2 (CB2) in modulating neuronal activity. Both receptors are capable of reducing neuronal activity, generating interest in cannabinoid receptor agonists as potential anticonvulsants. CB1 (Cnr1) and CB2 (Cnr2) single-knockout mice have been generated, with the former showing heightened seizure sensitivity, but not overt seizures. Given overlapping and complementary functions of CB1 and CB2 receptors, we queried whether double-knockout mice would show an exacerbated neurological phenotype. Strikingly, 30% of double-knockout mice exhibited provoked behavioral seizures, and 80% were found to be epileptic following 24/7 video-electroencephalographic monitoring. Single-knockout animals did not exhibit seizures. These findings highlight the importance of the endocannabinoid system for maintaining network stability. Wiley Periodicals, Inc.
© 2017 International League Against Epilepsy.

Entities:  

Keywords:  Cannabinoid receptors; Epilepsy; Spontaneous seizures

Mesh:

Substances:

Year:  2017        PMID: 29105060      PMCID: PMC5716894          DOI: 10.1111/epi.13930

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  15 in total

1.  CB1 cannabinoid receptors and on-demand defense against excitotoxicity.

Authors:  Giovanni Marsicano; Sharon Goodenough; Krisztina Monory; Heike Hermann; Matthias Eder; Astrid Cannich; Shahnaz C Azad; Maria Grazia Cascio; Silvia Ortega Gutiérrez; Mario van der Stelt; Maria Luz López-Rodriguez; Emilio Casanova; Günther Schütz; Walter Zieglgänsberger; Vincenzo Di Marzo; Christian Behl; Beat Lutz
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

2.  CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.

Authors:  Javier Palazuelos; Zaira Ortega; Javier Díaz-Alonso; Manuel Guzmán; Ismael Galve-Roperh
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

3.  Epilepsy and inflammation in the brain: overview and pathophysiology.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2014-01       Impact factor: 7.500

Review 4.  Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy.

Authors:  Ivan Soltesz; Bradley E Alger; Masanobu Kano; Sang-Hun Lee; David M Lovinger; Takako Ohno-Shosaku; Masahiko Watanabe
Journal:  Nat Rev Neurosci       Date:  2015-05       Impact factor: 34.870

5.  The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission.

Authors:  Asami Tanimura; Maya Yamazaki; Yuki Hashimotodani; Motokazu Uchigashima; Shinya Kawata; Manabu Abe; Yoshihiro Kita; Kouichi Hashimoto; Takao Shimizu; Masahiko Watanabe; Kenji Sakimura; Masanobu Kano
Journal:  Neuron       Date:  2010-02-11       Impact factor: 17.173

6.  Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

Authors:  A Vanessa Stempel; Alexander Stumpf; Hai-Ying Zhang; Tuğba Özdoğan; Ulrike Pannasch; Anne-Kathrin Theis; David-Marian Otte; Alexandra Wojtalla; Ildikó Rácz; Alexey Ponomarenko; Zheng-Xiong Xi; Andreas Zimmer; Dietmar Schmitz
Journal:  Neuron       Date:  2016-04-28       Impact factor: 17.173

7.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Authors:  A Zimmer; A M Zimmer; A G Hohmann; M Herkenham; T I Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 8.  Activity-dependent regulation of synapses by retrograde messengers.

Authors:  Wade G Regehr; Megan R Carey; Aaron R Best
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

9.  Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus.

Authors:  Robert E Blair; Laxmikant S Deshpande; Sompong Sombati; Katherine W Falenski; Billy R Martin; Robert J DeLorenzo
Journal:  J Pharmacol Exp Ther       Date:  2006-02-09       Impact factor: 4.030

10.  Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons.

Authors:  Floortje Remmers; Maren D Lange; Martina Hamann; Sabine Ruehle; Hans-Christian Pape; Beat Lutz
Journal:  Brain Struct Funct       Date:  2017-04-09       Impact factor: 3.270

View more
  15 in total

Review 1.  Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling.

Authors:  Yuki Sugaya; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2018-05-08       Impact factor: 9.261

2.  Selective Activation of Cannabinoid Receptor 2 Attenuates Myocardial Infarction via Suppressing NLRP3 Inflammasome.

Authors:  Wen Yu; Guangjun Jin; Jiancheng Zhang; Wei Wei
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 3.  G protein-coupled receptors in acquired epilepsy: Druggability and translatability.

Authors:  Ying Yu; Davis T Nguyen; Jianxiong Jiang
Journal:  Prog Neurobiol       Date:  2019-08-24       Impact factor: 11.685

4.  Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures.

Authors:  Parisa Zareie; Mehdi Sadegh; Mohammad Reza Palizvan; Homeira Moradi-Chameh
Journal:  Metab Brain Dis       Date:  2018-03-04       Impact factor: 3.584

5.  Δ9-Tetrahydrocannabinol inhibits Hedgehog-dependent patterning during development.

Authors:  Hsiao-Fan Lo; Mingi Hong; Henrietta Szutorisz; Yasmin L Hurd; Robert S Krauss
Journal:  Development       Date:  2021-10-05       Impact factor: 6.862

6.  The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome.

Authors:  Lyndsey L Anderson; Peter T Doohan; Nicole A Hawkins; Dilara Bahceci; Sumanta Garai; Ganesh A Thakur; Jennifer A Kearney; Jonathon C Arnold
Journal:  Neuropharmacology       Date:  2021-11-22       Impact factor: 5.273

7.  The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders.

Authors:  Qing Xin; Fei Xu; Devin H Taylor; Jing-Fu Zhao; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2020-10-06       Impact factor: 6.150

8.  Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.

Authors:  Lindsey Shapiro; Jennifer C Wong; Andrew Escayg
Journal:  Epilepsia       Date:  2019-11-22       Impact factor: 5.864

9.  Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.

Authors:  Ying Yu; Lexiao Li; Davis T Nguyen; Suni M Mustafa; Bob M Moore; Jianxiong Jiang
Journal:  Mol Neurobiol       Date:  2020-05-06       Impact factor: 5.590

10.  Identification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeutics.

Authors:  Qing-Rong Liu; Nicholas S Huang; Hong Qu; Jennifer F O'Connell; Isabel Gonzalez-Mariscal; Sara Santa-Cruz-Calvo; Maire E Doyle; Zheng-Xiong Xi; Yun Wang; Emmanuel S Onaivi; Josephine M Egan
Journal:  Acta Pharmacol Sin       Date:  2018-09-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.